CÚRAM aims to radically improve health outcomes for patients by developing ‘smart’ medical devices and implants. It develops these devices through collaborations with industry partners and hospital groups to enable their rapid translation to clinics.
CÚRAM positions Ireland as the driver in developing medical device technologies that will provide affordable transformative solutions for chronic diseases. The centre strengthens Ireland’s standing as a major global hub for medical device research and development.
CÚRAM’s research programme focuses on innovative design, assessment and manufacture of medical devices and is driven by specialist researchers, clinicians and industry partners, ultimately translating research into clinical settings.
Backed by €49.6m in SFI and industry funding, CÚRAM’s 250+ researchers are designing and manufacturing implants to respond to the body’s environment and delivering therapeutic agents exactly where they are needed. CÚRAM’s outputs will particularly benefit patients with chronic ailments such as heart disease, wound healing, diabetes and musculoskeletal diseases.
Industry Partners Include:
|Aerogen||Boston Scientific||Mylan Inc|
|Arch Therapeutics||Cook Medical||Neuravi|
CÚRAM work in partnership with Science Foundation Ireland and other SFI Research Centres to encourage education and public engagement initiatives. CÚRAM organise and develop local and national programmes including:
Prof Abhay Pandit - Centre Director
Abhay Pandit is Professor of Biomaterials at the National University of Ireland, Galway. In 2012 Prof Pandit was inducted as an International Fellow by the International Union of Societies for Biomaterials Science and Engineering (IUSBSE). He was elected Council Member of the European Society for Biomaterials Society in 2013. He has received numerous honours, including the Johnson & Johnson Healthcare Innovation Programme Award and the Academic/Emerging Medical Technology Company of the Year-Silver Award for 2013. In his industry career, Prof Pandit secured Food and Drug Administration clearance for a commercial wound dressing and Investigational Device Exemption approval for a collagen-based vascular sealant.
Dr Stefania Spada - Scientific Programme Manager
Dr. Neil Ferguson - Industry Programme Manager
Claire Riordan - Scientific Engagement Associate